Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Eylea Post Marketing Surveillance
Authors not listed
Bayer · 2014
Abstract
The objective of this PMS is to gain information about safety and efficacy in real practice as a regulatory commitment required by MFDS
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Anonymous. (2014). Eylea Post Marketing Surveillance. <em>Bayer</em>. https://clinicaltrials.gov/study/NCT01783925
Vancouver
Anonymous. Eylea Post Marketing Surveillance. Bayer. 2014.
BibTeX
@misc{anon2014EyleaP,
title = {Eylea Post Marketing Surveillance},
author = {Anonymous},
journal = {Bayer},
year = {2014},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Springer eBooks 2024
Citation only
Time-Restricted Eating: Safety and Efficacy in Youth
Oncotarget 2016
Open access · CC-BY
Safety of two-year caloric restriction in non-obese healthy individuals
Consorci Sanitari del Maresme 2025
Open access · US-GOV
Efficacy of Supplementation With Micronized Creatine Monohydrate in the Recovery of Muscle Mass, Muscle Strength and Functional Capacity in Older Adults Operated on for Total Knee Arthroplasty: Randomized Clinical Trial
The First Affiliated Hospital of Xiamen University 2021
Open access · US-GOV
A Phase II Study of Envafolimab as First-line Treatment of Aged Patients With High PD-L1 Expression Stage in Advanced Non-small-cell Lung Cancer(NSCLC)
AbbVie (prior sponsor, Abbott) 2009
Open access · US-GOV
A Randomized, Double-Blind, Active- and Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease
Ohr Pharmaceutical Inc. 2012
Open access · US-GOV